|
Collateral Disease Theory in Practice
Collateral disease theory emerged along with the establishment of the Yellow Emperor’s Inner Classic, as early as the Qin and Han dynasties. Throughout the development of TCM, the main channel system has been clearly emphasized, where the study of collateral disease has been inexplicably neglected. For the fi rst time in the history of Chinese Traditional Medicine, a book has been published in English that fully elaborates the physiology, pathology and treatment of collateral disease. This text can certainly benefi t the practitioners who wish to deepen their understanding of intractable diseases.
Authors
Dr. Jiang has been working with clinical studies, teaching and research in acupuncture related field for over 17 years and he is a highly respected physician by the community.
Professor Wu Yi-ling is a distinguished scholar of traditional Chinese medicine and doctoral supervisor at Hebei Medical University. He also acts as professor of integrative medicine at Hebei Medical University, chief physician and president of the Hebei Integrative Chinese-Western Medical Research Institute, and president of the Hebei Yiling Hospital affiliated to Hebei Medical University. Dr. Wu has been engaged in the study of collateral disease theory and application for over 20 years. As the leader of the scientific research program for the State Administration of Traditional Chinese Medicine (SATCM), he initiated the first systematic study on collateral disease theory and its exploratory development. He was the first to put forward the theoretical framework of collateral disease theory—the 3-D network system—and his continuing work aims to study collateral vessel theory from the unified view of time, space, and function. Remarkable achievements have been achieved due to his ongoing efforts in the study and treatment of diseases such as endothelial dysfunction of vascular lesions, atherosclerosis, vasospasm, acute myocardial infarction, cerebral infarction, and diabetic microangiopathy with collateral-unblocking drugs.
»BACK
|
